Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval.

AJ Mast | Bloomberg | Getty Images

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.)

Read More: World News | Entertainment News | Celeb News
CNBC

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Apple Vision Pro review: This is the future of computing and entertainment

Apple Vision Pro Todd Haselton | CNBC It’s night. I’m at a…

5 in-demand freelance jobs you can do from home—some pay over $200 an hour

More Americans are freelancing — and as demand for independent workers surges,…

Abrdn slashes 500 jobs as it is rocked by £12bn investor exodus

Exodus: Abrdn said assets under management hit a record low of £494.9bn…

Major central banks reached a pivotal point this week. Here’s what happened — and what’s next

U.S. Federal Reserve Chair Jerome Powell holds a press conference following a…